Literature DB >> 2048974

Immunological study of the nef protein from HIV-1 by polyclonal and monoclonal antibodies.

N Kienzle1, M Bröker, H P Harthus, M Enders, V Erfle, M Buck, N Müller-Lantzsch.   

Abstract

We constructed and expressed different overlapping fusion proteins with the nef gene of HIV-1 and generated specific polyclonal rabbit and monoclonal mouse antibodies against these recombinant proteins. The rabbit antisera, one of the monoclonal antibodies as well as a serum from a HIV-1 infected patient recognized the nef protein with Mr 27 kDa in latently HIV-1 infected glioma cells in the immunoblot. In contrast, these antibodies could not detect nef in productively HIV-1 infected Molt-3 cells neither in immunoblot nor in indirect immunofluorescence assays. These results indicate the possible participation of nef in viral latency. The recombinant nef proteins were used as probes for anti-nef antibodies in human sera. We observed in 17 of 57 sera tested specific anti-nef antibodies. All of these anti-nef positive sera also contained antibodies directed against viral structural proteins. The NH2-terminal region of the recombinant nef was shown to be the major immunodominant antigenic site in the immunoblot assay.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2048974     DOI: 10.1007/bf01311301

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  39 in total

1.  Segregation of New Lysogenic Types during Growth of a Doubly Lysogenic Strain Derived from Escherichia Coli K12.

Authors:  R K Appleyard
Journal:  Genetics       Date:  1954-07       Impact factor: 4.562

2.  Nucleotide sequence of the AIDS virus, LAV.

Authors:  S Wain-Hobson; P Sonigo; O Danos; S Cole; M Alizon
Journal:  Cell       Date:  1985-01       Impact factor: 41.582

3.  Human immunodeficiency virus type 1 negative factor is a transcriptional silencer.

Authors:  T M Niederman; B J Thielan; L Ratner
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Antibody response to the viral negative factor (nef) in HIV-1 infection: a correlate of levels of HIV-1 expression.

Authors:  P Reiss; A de Ronde; J M Lange; F de Wolf; J Dekker; C Debouck; J Goudsmit
Journal:  AIDS       Date:  1989-04       Impact factor: 4.177

6.  Long latency precedes overt seroconversion in sexually transmitted human-immunodeficiency-virus infection.

Authors:  A Ranki; S L Valle; M Krohn; J Antonen; J P Allain; M Leuther; G Franchini; K Krohn
Journal:  Lancet       Date:  1987-09-12       Impact factor: 79.321

7.  Analysis of adenovirus transforming proteins from early regions 1A and 1B with antisera to inducible fusion antigens produced in Escherichia coli.

Authors:  K R Spindler; D S Rosser; A J Berk
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

8.  Polymorphism of the 3' open reading frame of the virus associated with the acquired immune deficiency syndrome, human T-lymphotropic virus type III.

Authors:  L Ratner; B Starcich; S F Josephs; B H Hahn; E P Reddy; K J Livak; S R Petteway; M L Pearson; W A Haseltine; S K Arya
Journal:  Nucleic Acids Res       Date:  1985-11-25       Impact factor: 16.971

9.  Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins.

Authors:  Y Riviere; F Tanneau-Salvadori; A Regnault; O Lopez; P Sansonetti; B Guy; M P Kieny; J J Fournel; L Montagnier
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

10.  Identification of the coding region for a second Epstein-Barr virus nuclear antigen (EBNA 2) by transfection of cloned DNA fragments.

Authors:  N Mueller-Lantzsch; G M Lenoir; M Sauter; K Takaki; J M Béchet; C Kuklik-Roos; D Wunderlich; G W Bornkamm
Journal:  EMBO J       Date:  1985-07       Impact factor: 11.598

View more
  4 in total

1.  Expression and cellular localization of the Nef protein from human immunodeficiency virus-1 in stably transfected B-cells.

Authors:  N Kienzle; M Bachmann; W E Müller; N Müller-Lantzsch
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  Expression of the HIV-1 Nef protein in the baculovirus system: investigation of anti-Nef antibodies response in human sera and subcellular localization of Nef.

Authors:  N Kienzle; M Enders; M Buck; H Siakkou; S Jahn; G Petzold; K E Schneweis; M Bachmann; W E Müller; N Müller-Lantzsch
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

3.  Subcloning of HIV-2 nef genes in E. coli and immunological reactivity of expressed fusion proteins.

Authors:  R Ulrich; H Siakkou; J Mayer; N Kienzle; N Müller-Lantzsch; D H Krüger
Journal:  Virus Genes       Date:  1993-09       Impact factor: 2.332

4.  Fine mapping of HIV-1 Nef-epitopes by monoclonal antibodies.

Authors:  H Siakkou; S Jahn; N Kienzle; R Ulrich; C Grötzinger; T Schneider; B Kohleisen; G Pauli; R Spohn; G Jung
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.